July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Matrix Gla Functions as a Keeper of Physiological Intraocular Pressure (IOP) in the Mouse Eye
Author Affiliations & Notes
  • Terete Borras
    Department of Ophthalmology, University of North Carolina, Chapel Hill, North Carolina, United States
    Gene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
  • Priyadarsini Asokan
    Department of Ophthalmology, University of North Carolina, Chapel Hill, North Carolina, United States
  • Millena Sivakumar
    Physics and Astronomy, Univ of NC at Chapel Hill, Chapel Hill, North Carolina, United States
  • Michael R. Falvo
    Physics and Astronomy, Univ of NC at Chapel Hill, Chapel Hill, North Carolina, United States
  • Footnotes
    Commercial Relationships   Terete Borras, None; Priyadarsini Asokan, None; Millena Sivakumar, None; Michael Falvo, None
  • Footnotes
    Support  NIH: EY026220, UNC internal award
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 5209. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Terete Borras, Priyadarsini Asokan, Millena Sivakumar, Michael R. Falvo; Matrix Gla Functions as a Keeper of Physiological Intraocular Pressure (IOP) in the Mouse Eye. Invest. Ophthalmol. Vis. Sci. 2019;60(9):5209.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Matrix Gla (MGP) is an inhibitor of calcification gene highly expressed in arteries’ smooth muscle cells, chondrocytes, trabecular meshwork (TM) & peripapillary sclera. In mice, ablation of Mgp is lethal. Here we seek to determine the role of MGP in maintaining physiological IOP by generating and assessing a TM conditional knock-out mouse (Mgp-TM.cKO).

Methods : A Mgp floxed transgenic mouse (Mgp-loxP) was generated by inserting loxP sequences flanking Mgp exons 3 & 4 using CRISPR/CAS9 technology. Primary mouse angle cells were generated from Mgp-loxP mice and age-matched WT. Viral vectors Ad-GFP-2A-iCre (Ad.Cre) and Ad-CMV-GFP (control) were grown to high titers. Mgp floxed cells and Mgp-loxP mice were infected/ injected with Ad.Cre and control viruses. Mice injections were intracameral (IC) with 1-5 X 109 ifu at 2.5 month using a 33G NanoFil needle and a Micro-2T syringe pump. IOPs were measured at pre-injection and weekly post-injection for 75 d on sedated mice using a TonoLab. Mechanical force is being determined on the TM region of 10 µm unfixed cryosections using an MFP-3D Bio AFM (Asylum).

Results : Ad.Cre gene delivery to Mgp-floxed cells and TM of Mgp-LoxP living mice resulted in 80-90% floxed Mgp genomic DNA, ablation of Mgp protein and generation of a Mgp-TM.cKO mice. Mgp ablation did not occur on Mgp-LoxP cells & mice treated with control viruses, on WT cells & mice treated with Ad.Cre, or when left untreated. The eyes of Mgp-TM.cKO mice (n=31) exhibit significant elevated IOP while those of the three control groups (n=29, n=22 & n=10) had baseline pressures at the same time-periods. Pressures in the Mgp-TM.cKO mice began to increase at 2 wks post-injection and continued to day 75, when the experiment was terminated. At 4 wks the Mgp-TM.cKO’s IOP was 13.0±0.6 mmHg vs 8.9±0.1, 8.4±0.2 & 8.0±0.03 mmHg on the three controls (P<0.0001 all comparisons). At 10 wks (last point), the Mgp-TM.cKO’s IOP was 24.1±0.9 mmHg vs 9.3±0.1, 8.0±0.1 & 8.1±0.3 mmHg on controls (P<0.0001 all). A preliminary non-statistical AFM study assay suggests Mgp-TM.cKO TM tissue may be stiffer than that of the control.

Conclusions : Mgp’s ablation in the TM leads to elevated IOP in living mice. This suggests that Mgp’s role in the eye is that of maintaining physiological IOP. Because Mgp prevents arterial calcification, it is possible that Mgp is preventing hardening and stiffness of the TM.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×